Dermatology Times

APRIL 4, 2025

Sherket Peterson, PhD, spoke to Dermatology Times about Allergans recent research and plan to launch a universal skin quality index.

Dermatology 65

Dermatology 65

Salon Today

APRIL 4, 2025

More and more consumers are seeking out sustainable products and businessesis your salon giving them what theyre looking for?

Sustainability 52

Sustainability Salon 52

Beauty Launchpad

APRIL 4, 2025

The Texture vs Race Summit (TVR), founded by industry changemaker Keya Neal, announces its return to Baltimore from May 4-6, 2025, at the historic Frederick Douglass-Isaac Myers Maritime Park Museum.

Technology 52

Technology Education 52

Salon Today

APRIL 4, 2025

Are skyrocketing costs putting pressure on your color business? Meet five salon owners and find out what they are doing differently to stay profitable.

Salon 52

Salon 52

Dermatology Times

APRIL 4, 2025

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dermatology 36

Dermatology 36

Salon Today

APRIL 4, 2025

Discover the future of haircutting with Calligraphy Cutan innovative technique that transforms hair health, enhances stylist creativity, and boosts salon revenue. Learn how just one tool can elevate client satisfaction and generate up to $52,000 more per stylist annually.

Tools 52

Tools Innovations Salon 52

Salon Today

APRIL 4, 2025

Once sold exclusively in-salon, professional hair care products are now widely available online. This shift has significantly impacted salon retail sales, as big box and specialty retailers have moved in, meeting consumers where they want to shop and when they are ready to purchase. Discover how leveraging eCommerce and innovative marketing strategies can help salons reclaim retail revenue and build lasting client loyalty in this evolving market.

Salon 52

Salon Sales Marketing Innovations 52

Dermatology Times

APRIL 4, 2025

Panelists discuss how clinicians can recognize and address barriers to treatment advancement in a young adult with persistent moderate to severe atopic dermatitis by evaluating disease impact, patient concerns, and appropriate therapeutic options.

Dermatitis 36

Dermatitis Treatments 36

Lipgloss and Aftershave

APRIL 4, 2025

We love a skincare innovation that sticks the landingliterally. And the latest launch from the award-winning acne experts at Face Reality Skincare is doing just that. Get ready to meet your blemishs new worst enemy: the Face Reality InvisiClear patch. These professional-grade hydrocolloid patches arent just another pretty sticker in your skincare arsenal.

Sales 52

Sales Skincare Scarring Skin Types 52

Dermatology Times

APRIL 4, 2025

Panelists discuss how to optimize treatment outcomes by managing the transition from biologics to JAK inhibitors and considering dose adjustment strategies when patients show inadequate response to initial therapy.

Therapy 36

Therapy Management Treatments 36

Lipgloss and Aftershave

APRIL 4, 2025

In the last two decades, the convergence of botanical science and dermatology has transitioned from folklore into evidence-based therapeutics. No longer confined to traditional medicine, bioactive skincare ingredients derived from botanicals are now recognized for their diverse compounds that target skin health at the molecular level. In this article, we explore the functional impact of plant-based constituentsparticularly antioxidants, anti-inflammatories, and antimicrobial agentsand examine ke

Vitamin C 52

Vitamin C Ingredients Collagen Skincare 52

Dermatology Times

APRIL 4, 2025

A cross-sectional survey revealed that many patients with HS are dissatisfied with treatment options, with gaps in knowledge about FDA-approved therapies.

Therapy 36

Therapy Treatments 36

Lipgloss and Aftershave

APRIL 4, 2025

A Preview of L+A’s April Focus: Botan-Clinical Meets Tech-Nature Spring symbolizes new beginningsand in skincare, it’s the perfect time to renew your approach. At L+A, were spotlighting science-backed natural skincare, a powerful blend of botanical ingredients and advanced aesthetic technology. This emerging Tech-Nature trend is designed for skincare professionals who demand clinical-grade results, with a holistic edge.

Clinic 52

Clinic Skincare Technology Consultation 52

Dermatology Times

APRIL 4, 2025

Studies show that exposure to meaningful artwork can lower blood pressure and enhance mental clarity in patients.

Clinic 36

Clinic 36

Lipgloss and Aftershave

APRIL 4, 2025

On May 17th , we invite you to join us at Colab Space in Irvine, CA , for an empowering and transformative Womens Health Event called EmbodyHER a day dedicated to clean beauty, wellness, and the honest conversations we need to be having about modern womanhood, hosted by Dr. Chantal Lunderville, our Medical and Wellness Editor and Ektha Aggarwal, LCSW.

Medical 52

Medical Injections Skincare Tools 52

Dermatology Times

APRIL 4, 2025

The study found dupilumab-treated patients had the highest probability of remaining infection-free over 52 weeks.

Therapy 36

Therapy 36

Alison Bladh

APRIL 4, 2025

Sweet Potato Fudge Brownies A Healthy Take on a Classic Favourite We all enjoy something indulgent now and again and with these Sweet Potato Fudge Brownies, you can savour the moment while still staying aligned with your healthy lifestyle. This recipe is rich, chocolatey and made with nourishing ingredients that offer a more balanced way to enjoy a sweet treat.

Extractions 52

Extractions Ingredients 52

Dermatology Times

APRIL 4, 2025

Aaron Farberg, MD, discuss how JAK inhibitors have come under scrutiny in the past for systemic adverse effects in oral formulations, while exploring the safety data of topical JAK inhibitors in the pediatric population, which appears to show a more favorable risk profile with localized effects.

Safety 36

Safety 36

The Dermatology Digest

APRIL 4, 2025

Sun Pharma is partnering with Art Garfunkel, who is sharing his story of living with moderate-to-severe plaque psoriasis in-depth for the first time publicly. The Grammy Award-winning artist and Rock and Roll Hall of Fame inductee will be talking about his experience with tildrakizumab-asmn (Ilumya) as part of the “I LUV YA for The Long Haul” campaign. “With support from my wife, Kim, and a treatment I trust, I am finally ready to give my history with psoriasis a voice,”

Partnerships 41

Partnerships Treatments Marketing Branding 41

Dermatology Times

APRIL 4, 2025

Aaron Farberg, MD, discuss how appropriate monitoring, including regular assessments of growth, potential side effects, and laboratory tests to evaluate liver function and hematologic parameters, would be necessary when prescribing a topical JAK inhibitor to a younger child (age 2-11 years).

36

36

Fairlawn Aesthetic MD

APRIL 4, 2025

In the quest for youthful and radiant skin, Intense Pulsed Light (IPL) treatment emerges as a popular choice for many seeking to rejuvenate their appearance without invasive procedures. Offered by trusted providers like Fairlawn Aesthetic MD, IPL skin rejuvenation might just be the solution you’re looking for. But how does it work, and is it right for you?

Hair Removal 36

Hair Removal Rosacea Skin Types Therapy 36

Dermatology Times

APRIL 4, 2025

Aaron Farberg, MD, discuss how to educate parents about the potential adverse effects of a new therapy while also reassuring them about its overall safety profile by providing clear, evidence-based information and emphasizing the rigorous testing and monitoring processes.

Safety 36

Safety Education Therapy 36

Dermatology Times

APRIL 4, 2025

An expert discusses when gene expression profile (GEP) testing is recommended for melanoma and squamous cell carcinoma (SCC) patients, including cases where it may not be necessary, and provides final thoughts on the utility of GEP testing in risk stratification and making treatment decisions.

Treatments 36

Treatments 36

Dermatology Times

APRIL 4, 2025

Tremfya is the first IL-23 inhibitor to significantly improve both symptoms and structural damage in active psoriatic arthritis.

41

41

Dermatology Times

APRIL 4, 2025

Panelists discuss how IL-17 inhibitors are considered for plaque psoriasis based on disease severity, comorbidities, and patient preference. Selection factors include efficacy, safety, access, and cost. Clinical trial data guide choices, but real-world factors impact use. Dosing varies: secukinumab (300 mg weekly for 5 weeks, then monthly), ixekizumab (160 mg at week 0, then 80 mg biweekly for 12 weeks, then monthly), brodalumab (210 mg weekly for 3 weeks, then biweekly), and bimekizumab (320 mg

Safety 41

Safety Clinic 41

Dermatology Times

APRIL 4, 2025

Aaron Farberg, MD, discusses how, when prescribing therapies for pediatric patients, dermatologists prioritize long-term safety alongside efficacy. Topical Janus kinase (JAK) inhibitors have demonstrated a favorable safety profile compared with their oral counterparts, with minimal systemic absorption. Appropriate monitoring may include baseline blood work and periodic clinical assessments, particularly in younger children.

Safety 36

Safety Dermatitis Treatments Therapy 36

Dermatology Times

APRIL 4, 2025

An expert discusses their impressions of the case, classifying the patients risk based on the clinical presentation of the lesion, and outlines treatment recommendations without knowing the 40-gene expression profile (GEP) information, including whether adjuvant therapy (ART) would be recommended. The expert also shares how to discuss 40-GEP testing with patients and reassure them that accurate risk levels are crucial for receiving optimal treatment.

Treatments 36

Treatments Therapy Clinic 36

Dermatology Times

APRIL 4, 2025

Panelists discuss how IL-17 inhibitors are generally well-tolerated, but common adverse effects include infections, particularly candidiasis, and potential increased suicidal ideation risk. Patients should be informed of candidiasis risk, especially with bimekizumab (Gordon, 2022), and monitored for mood changes, as IL-17s and IL-23s may impact mental health (Blauvelt, 2023).

Safety 36

Safety Treatments 36